Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 8 Biotech Stock Controversies Emerging From 'JPM15' Conference
8 Biotech Stock Controversies Emerging From 'JPM15' Conference
8 Biotech Stock Controversies Emerging From 'JPM15' Conference
Submitted by
admin
on January 20, 2015 - 11:33am
Source:
TheStreet.com
News Tags:
JPMHC 2015
drug pricing
CAR-T
biotech
Gilead Sciences
immuno-oncology
Duchenne Muscular Dystrophy
Headline:
8 Biotech Stock Controversies Emerging From 'JPM15' Conference
Do Not Allow Advertisers to Use My Personal information
